Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression

被引：0
|
作者：
Katelin R. Haynes
Hsu-Wen Tseng
Michaela Kneissel
Tibor T. Glant
Matthew A. Brown
Gethin P. Thomas
机构：
[1] Translational Research Institute,The University of Queensland Diamantina Institute
[2] Princess Alexandra Hospital,Musculoskeletal Disease Area
[3] Novartis Institutes for Biomedical Research,Section of Molecular Medicine, Department of Orthopedic Surgery
[4] Rush University Medical Center,undefined
来源：
BMC Musculoskeletal Disorders | / 16卷
关键词：
Ankylosing spondylitis; Sclerostin; Wnt inhibitor; Mouse model; Bone formation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Coexistence of ankylosing spondylitis and Behçet's disease: Successful treatment with upadacitinib
    Kraev, Krasimir
    Uchikov, Petar
    Hristov, Bozhidar
    Kraeva, Maria
    Basheva-Kraeva, Yordanka
    Popova-Belova, Stanislava
    Sandeva, Milena
    Chakarov, Dzhevdet
    Dragusheva, Snezhanka
    Geneva-Popova, Mariela
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (04)
  • [32] TRIMETHOPRIME-SULFAMETHOXAZOLE AS TREATMENT OF A CASE OF WHIPPLES DISEASE WITH ANKYLOSING-SPONDYLITIS
    BLAISON, D
    CARTERET, E
    RENARD, P
    LELOUARGANT, M
    DIEBOLD, MD
    LECOCQ, P
    BROCHOT, P
    GOUGEON, J
    ZEITOUN, P
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1991, 27 (02): : 51 - 55
  • [33] The effect of anti-TNF treatment on osteoblastogenesis in ankylosing spondylitis: the number of circulating osteoblast-lineage cells in peripheral blood decreased after infliximab therapy in patients with ankylosing spondylitis
    Kwon, S. -R.
    Jung, K. -H.
    Lim, M. -J.
    Son, M. -J.
    Choi, B. H.
    Park, S. -G.
    Park, W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (05) : 837 - 843
  • [34] Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatment
    Derdemezis, C. S.
    Filippatos, T. D.
    Voulgari, P. V.
    Tselepis, A. D.
    Drosos, A. A.
    Kiortsis, D. N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (06) : 880 - 883
  • [35] Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis
    H. Toktas
    E. Okur
    U. Dundar
    A. Dikici
    O. K. Kahveci
    Clinical Rheumatology, 2014, 33 : 1481 - 1487
  • [36] Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes
    Tseng, Hsu-Wen
    Pitt, Miranda E.
    Glant, Tibor T.
    McRae, Allan F.
    Kenna, Tony J.
    Brown, Matthew A.
    Pettit, Allison R.
    Thomas, Gethin P.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [37] Interleukin-6 serum concentration in ankylosing spondylitis: a reliable predictor of disease progression in the subsequent year?
    Falkenbach, A
    Herold, M
    Wigand, R
    RHEUMATOLOGY INTERNATIONAL, 2000, 19 (04) : 149 - 151
  • [38] Interleukin-6 serum concentration in ankylosing spondylitis: a reliable predictor of disease progression in the subsequent year?
    A. Falkenbach
    M. Herold
    R. Wigand
    Rheumatology International, 2000, 19 : 149 - 151
  • [39] Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes
    Hsu-Wen Tseng
    Miranda E. Pitt
    Tibor T. Glant
    Allan F. McRae
    Tony J. Kenna
    Matthew A. Brown
    Allison R. Pettit
    Gethin P. Thomas
    Arthritis Research & Therapy, 18
  • [40] Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis
    Ajrawat, Prabjit
    Touma, Zahi
    Sari, Ismail
    Taheri, Cameron
    Martinez, Juan Pablo Diaz
    Haroon, Nigil
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (06) : 728 - 743
12345